AstraZeneca
AZNH
AZNH was delisted on the 29th of January, 2026.
1 hedge funds and large institutions have $602K invested in AstraZeneca in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
75.91% less ownership
Funds ownership: 87.01% → 11.1% (-76%)
85% less capital invested
Capital invested by funds: $4.02M → $602K (-$3.42M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$4.02M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $602K | -$4.02M | -75,911 | -87% |
|
AZNH Hedge Fund Activity: Q4 2025 in Review
1 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZNH) for Q4 2025, worth a combined $602K — down 85% from $4.02M a quarter earlier.
Fund positioning in AZNH was balanced in Q4 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Citadel Advisors, cutting an estimated $4.02M.
- 1 institutional investor held AstraZeneca (AZNH) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $602K of AstraZeneca stock for Q4 2025, down 85% quarter-over-quarter.
- 0 funds opened new AstraZeneca positions in Q4 2025 and 0 closed out.
- The largest AstraZeneca seller in Q4 2025 was Citadel Advisors, an estimated $4.02M sold.
Based on aggregated 13F filings for Q4 2025.